跳至主要内容
临床试验/ACTRN12606000205538
ACTRN12606000205538已完成不适用

Prednisolone and Infliximab for Polymyalgia Rheumatica: Evaluation of the safety and efficiacy of Infliximab in maintaining Corticosteroid-induced remission and in sparing Corticosteroids

Hospital S. Maria Nuova, Reggio Emilia Italy0 个研究点目标入组 51 人开始时间: 2006年5月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
51

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
50 Years 至 ot stated(—)
性别
All

入选标准

  • Consecutive adult patients who satisfy Healey’s criteria for the diagnosis of PMR will be included in the study.

排除标准

  • 1) Patients previously treated with corticosteroids; 2) Patients with clinical and/or histological evidence of giant cell arteritis; 3) Uncontrolled diabetes and hypertension, infection and neoplasm;4) Active or inactive (latent) Tuberculosis (TB), evaluated by detailed medical history (including personal history of TB, possible previous contacts with TB, and family history of TB), chest X-rays (performed in the 2 months prior entering the study), and PPD test. If any of those are positive or suggestive of TB the patient can not be enrolled.

研究者

发起方
Hospital S. Maria Nuova, Reggio Emilia Italy

相似试验

进行中(未招募)
不适用
Infliximab en pacientes con polimialgia reumática refractaria a corticoides. Ensayo doble ciego controlado con placebo. (Infliximab in patients with rheumatic polymyalgia refractory to corticosteroids. Double blind placebo controlled trial).Polimialgia reumática (Rheumatic polymyalgia).MedDRA version: 8.1Level: PTClassification code 10036099Term: Polymyalgia rheumatica
EUCTR2006-001081-16-ESVictor Martínez Taboada
Unknown
3 期
Infliximab Therapy in Patients With Refractory Polymyalgia RheumaticaPolymyalgia Rheumatica
NCT01423591Hospital Universitario Marqués de Valdecilla23
已完成
不适用
A combination of prednisolone and mizoribine and a combination of prednisolone, mizoribine, warfarin and dipyridamole for IgA nephropathy with diffuse mesangial prolideration in children:A randomized controlled trial of efficacy and safetyIgA nephropathy in children
JPRN-C000000363The Japanese Pediatric IgA Nephropathy of Treatment Study Group80
已完成
不适用
Medical care of patients with polymyalgia rheumatica: evaluation of guideline-based care and treatment using claims dataPolymyalgia rheumaticaM35.3M31.5Giant cell arteritis with polymyalgia rheumatica
DRKS00028043AOK Baden-Württemberg27,079
已完成
不适用
Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06)Steroid-sensitive nephrotic syndrome
JPRN-C000000379Japanese Study Group of Renal Disease in Children(JSRDC)50